TCS 183, a peptide, is a GSK-3beta inhibitor. TCS 183 blocks GSK-3beta autoinhibition and decreases the level of AMPK phosphorylation. TCS 183 can be used for neuropathological diseases, particularly Alzheimers disease, research[1].
Molecular Weight:
1425.57
Formula:
C58H96N20O20S
Target:
GSK-3,p38 MAPK
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
